GLP-1 / Metabolic Research

Tirzepatide / TR Series

Eight vial-strength options organized under one compound-level technical and quotation workflow.

Representative Tirzepatide TR series vial and packaging
9Listed specifications
5-60 mg/vialSpecification range
Vial / bulkSupply scope
Lot-specificTechnical review

TR Series Specifications

All listed Tirzepatide SKUs.

Compare the listed vial strengths and pack formats. Final availability and lot documents are confirmed during technical review.

SKUVial strengthPack formatSupply scope
TR5Tirzepatide 5 mg/vial 10 vials/kit Lyophilized vial / bulk custom
TR10Tirzepatide 10 mg/vial 10 vials/kit Lyophilized vial / bulk custom
TR15Tirzepatide 15 mg/vial 10 vials/kit Lyophilized vial / bulk custom
TR20Tirzepatide 20 mg/vial 10 vials/kit Lyophilized vial / bulk custom
TR30Tirzepatide 30 mg/vial 10 vials/kit Lyophilized vial / bulk custom
TR40Tirzepatide 40 mg/vial 10 vials/kit Lyophilized vial / bulk custom
TR50Tirzepatide 50 mg/vial 10 vials/kit Lyophilized vial / bulk custom
TR60Tirzepatide 60 mg/vial 10 vials/kit Lyophilized vial / bulk custom
TR100Tirzepatide 100 mg/vial 10 vials/kit Lyophilized vial / bulk custom

Compound-Level Reference

Shared technical identity

Vial strength changes the presentation specification. Compound identity and final lot results remain controlled by the selected batch documents.

CAS / identity
2023788-19-2
Molecular formula
C225H348N48O68
Purity program
Target ≥98% by HPLC; lot result on COA
Analytical package
Lot COA, HPLC chromatogram, LC-MS identity review

B2B Technical Review

Request a quotation for the TR series with the required SKU, volume, packaging, and destination.